Optical coherence tomography angiography features of macular neovascularization in wet age-related macular degeneration: A cross-sectional study.
Age related macular degeneration
Macular neovascularization
Optical coherence tomography angiography
Journal
Annals of medicine and surgery (2012)
ISSN: 2049-0801
Titre abrégé: Ann Med Surg (Lond)
Pays: England
ID NLM: 101616869
Informations de publication
Date de publication:
Oct 2021
Oct 2021
Historique:
received:
06
08
2021
revised:
04
09
2021
accepted:
05
09
2021
entrez:
20
9
2021
pubmed:
21
9
2021
medline:
21
9
2021
Statut:
epublish
Résumé
OCT-A is a recent imaging technique allowing a non-invasive assessment of the retinal and choroidal microvasculature, providing valuable data for the diagnosis and monitoring of wet AMD. We aim to determine the diagnosis accuracy, describe the morphological features, and assess the clinical activity of MNV in wet AMD using OCT-A. We conducted a descriptive cross-sectional study over a 15-month period. We enrolled patients with treatment-naive and treated MNV secondary to wet AMD. Macular OCT-A images were obtained using a swept-source OCT-A device (Triton SS-OCT, Topcon, Tokyo, Japan). Morphologic characteristics and semi-automated measurements were analyzed on the en face projection OCT-Angiograms. For the qualitative analysis, determined the sensitivity of detection of the MNV using OCTA. When detected, we described its shape, branching pattern, anastomoses and loops, and vessel termination. We looked for the halo sign and the feeder vessel. We then defined the lesion's "pattern" reflecting its exudative activity. For the quantitative analysis, we measured the lesion's area in square millimeters, when its borders were clearly defined. 70 eyes from 55 patients were enrolled in this study. Type 1 MNV was identified in 57,1% eyes, type 2 in 21,4%, mixed type 1 and2 in 1,4%, type 3 in 1,4% and unclassified fibrotic MNV in 18,6%. 55,7% were active and 44,3% were inactive. Sensitivity of detection was 85% for type 1 lesions, 100% for type 2, mixed and type 3 lesions, and 92% for unclassified fibrotic lesions. It was 84,6% for active lesions and 96,8% for inactive lesions. For each detected lesion, shape was well-defined (medusa, glomerulus, seafan), long liner vessels or ill-defined. Branching pattern was dense or loose. Anastomoses and vascular loops were numerous or few. Termination was in an anastomotic arcade or in a dead-tree aspect. Halo sign was present or absent and feeder vessel was detected or not. All types combined, 41,3% of the lesions were "pattern I" and 58,7% were pattern II. We reported a correlation rate of 84,8% between the lesion's activity on MI and « pattern I » on OCT-A, and of 96,6% between absence of activity signs on MI and « pattern II » on OCT-A The mean area of inactive lesions was slightly larger than that of active lesions with respective values of 3.86 mm OCT-A is a non-invasive, safe, and reproducible retinal imaging technique with a high sensitivity of detection of MNV in AMD. It provides useful qualitative and quantitative data. The involvement of OCT-A in the treatment decision for MNV in AMD is linked to identifying the "pattern" of the lesion reflecting its active or inactive status.
Sections du résumé
BACKGROUND
BACKGROUND
OCT-A is a recent imaging technique allowing a non-invasive assessment of the retinal and choroidal microvasculature, providing valuable data for the diagnosis and monitoring of wet AMD. We aim to determine the diagnosis accuracy, describe the morphological features, and assess the clinical activity of MNV in wet AMD using OCT-A.
MATERIALS AND METHODS
METHODS
We conducted a descriptive cross-sectional study over a 15-month period. We enrolled patients with treatment-naive and treated MNV secondary to wet AMD. Macular OCT-A images were obtained using a swept-source OCT-A device (Triton SS-OCT, Topcon, Tokyo, Japan). Morphologic characteristics and semi-automated measurements were analyzed on the en face projection OCT-Angiograms. For the qualitative analysis, determined the sensitivity of detection of the MNV using OCTA. When detected, we described its shape, branching pattern, anastomoses and loops, and vessel termination. We looked for the halo sign and the feeder vessel. We then defined the lesion's "pattern" reflecting its exudative activity. For the quantitative analysis, we measured the lesion's area in square millimeters, when its borders were clearly defined.
RESULTS
RESULTS
70 eyes from 55 patients were enrolled in this study. Type 1 MNV was identified in 57,1% eyes, type 2 in 21,4%, mixed type 1 and2 in 1,4%, type 3 in 1,4% and unclassified fibrotic MNV in 18,6%. 55,7% were active and 44,3% were inactive. Sensitivity of detection was 85% for type 1 lesions, 100% for type 2, mixed and type 3 lesions, and 92% for unclassified fibrotic lesions. It was 84,6% for active lesions and 96,8% for inactive lesions. For each detected lesion, shape was well-defined (medusa, glomerulus, seafan), long liner vessels or ill-defined. Branching pattern was dense or loose. Anastomoses and vascular loops were numerous or few. Termination was in an anastomotic arcade or in a dead-tree aspect. Halo sign was present or absent and feeder vessel was detected or not. All types combined, 41,3% of the lesions were "pattern I" and 58,7% were pattern II. We reported a correlation rate of 84,8% between the lesion's activity on MI and « pattern I » on OCT-A, and of 96,6% between absence of activity signs on MI and « pattern II » on OCT-A The mean area of inactive lesions was slightly larger than that of active lesions with respective values of 3.86 mm
CONCLUSION
CONCLUSIONS
OCT-A is a non-invasive, safe, and reproducible retinal imaging technique with a high sensitivity of detection of MNV in AMD. It provides useful qualitative and quantitative data. The involvement of OCT-A in the treatment decision for MNV in AMD is linked to identifying the "pattern" of the lesion reflecting its active or inactive status.
Identifiants
pubmed: 34540215
doi: 10.1016/j.amsu.2021.102826
pii: S2049-0801(21)00776-7
pmc: PMC8435926
doi:
Types de publication
Journal Article
Langues
eng
Pagination
102826Informations de copyright
© 2021 The Authors.
Déclaration de conflit d'intérêts
We declare that there is no conflict of interest.
Références
Eye (Lond). 2019 Aug;33(8):1280-1289
pubmed: 30932032
J Clin Med. 2019 Aug 22;8(9):
pubmed: 31443399
Opt Express. 2012 Feb 13;20(4):4710-25
pubmed: 22418228
Retina. 2015 Nov;35(11):2275-84
pubmed: 26457397
Am J Ophthalmol. 2015 Jul;160(1):6-16
pubmed: 25887628
Lancet. 2018 Sep 29;392(10153):1147-1159
pubmed: 30303083
Graefes Arch Clin Exp Ophthalmol. 2017 Aug;255(8):1535-1542
pubmed: 28474129
Acta Ophthalmol. 2013 Sep;91(6):e474-81
pubmed: 23848133
Ophthalmic Surg Lasers Imaging Retina. 2016 Jun 1;47(6):517-22
pubmed: 27327280
Ophthalmologica. 2020;243(2):120-128
pubmed: 31665719
Lancet Glob Health. 2014 Feb;2(2):e106-16
pubmed: 25104651
Retina. 2015 Nov;35(11):2212-8
pubmed: 26441269
Ophthalmology. 2003 Jan;110(1):15-21; quiz 22-3
pubmed: 12511340
Retina. 2015 Nov;35(11):2252-9
pubmed: 26457400
Br J Ophthalmol. 2018 Jun;102(6):821-826
pubmed: 28855197
Ophthalmology. 2020 May;127(5):616-636
pubmed: 31864668
Ophthalmol Retina. 2017 Sep-Oct;1(5):435-447
pubmed: 29034359
Eur J Ophthalmol. 2018 Jul;28(4):349-357
pubmed: 29623720
JAMA. 2004 Apr 21;291(15):1900-1
pubmed: 15108691
Am J Ophthalmol. 2015 Oct;160(4):739-48.e2
pubmed: 26164826
Int J Surg. 2019 Dec;72:156-165
pubmed: 31704426
Retina. 2018 Feb;38(2):220-230
pubmed: 28582276
Retina. 2015 Nov;35(11):2219-28
pubmed: 26398697
Dev Ophthalmol. 2016;56:57-61
pubmed: 27023917
Am J Ophthalmol. 2016 Sep;169:189-198
pubmed: 27394033
Retina. 2017 Oct;37(10):1873-1879
pubmed: 28079756
Ophthalmology. 2014 Jul;121(7):1435-44
pubmed: 24679442
Acta Ophthalmol. 2017 Jun;95(4):414-420
pubmed: 28133946
Am J Ophthalmol. 1967 Mar;63(3):Suppl:1-139
pubmed: 6019308
Eye (Lond). 2021 Feb;35(2):644-650
pubmed: 32398845
Retina. 2018 Nov;38(11):2143-2149
pubmed: 28902095
Dev Ophthalmol. 2016;56:52-6
pubmed: 27023798
PLoS One. 2018 Oct 9;13(10):e0205513
pubmed: 30300393
Dev Ophthalmol. 2016;56:86-90
pubmed: 27023067
Ophthalmol Retina. 2017 Jul-Aug;1(4):294-303
pubmed: 29057386
Retina. 2015 Nov;35(11):2229-35
pubmed: 26502007
Br J Ophthalmol. 2019 Sep;103(9):1342-1346
pubmed: 30467129
Am J Ophthalmol. 2011 Nov;152(5):799-806.e1
pubmed: 21742302